CBX4 and head and neck cancer: Moreover, subsequent gene enrichment analysis indicated significant enrichment of head and neck cancer-related pathways in the group characterized by high CBX4 expression (Normalized Enrichment Score, NES = 2.48), suggesting the involvement of CBX4 in promoting aggressive tumor behavior (Figure 1C).